Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs - Top-Institutions - MDSpire

Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs

  • By

  • Kerry R. Love

  • Stacy E. Martin

  • Laura Crowell Orella

  • May 18, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatrics
    • Immunology

  • #2

    Texas Children’s Hospital
    Texas Children’s Hospital

    Houston, Texas

    Key Differentiators

    • Pediatrics
    • Vaccine Development

  • #3

    Rady Children’s Hospital–San Diego
    Rady Children’s Hospital–San Diego

    San Diego, California

    Key Differentiators

    • Pediatrics
    • Hematology-Oncology

  • #4

    UC San Diego Health
    UC San Diego Health

    La Jolla, California

    Key Differentiators

    • Pediatrics
    • Hematology-Oncology

  • #5

    Hospital General
    Hospital General

    Tijuana, Baja California

    Key Differentiators

    • Pediatrics
    • Oncology

Original Source(s)

Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs

  • by Kerry R. Love, Stacy E. Martin, Laura Crowell Orella

  • May 18, 2026

Related Content

Rare Ebola Strain Sparks Global Alert

CDC urges travelers returning from Central Africa to monitor for Ebola symptoms for 21 days.

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.